-The Indian Express Gay rights activists today submitted in Supreme Court that criminalising homosexual acts is against constitutional values and that the law should not interfere when consenting adults are involved. Naz Foundation, an NGO working for the welfare and rehabilitation of HIV infected people, contended that homosexuals face social ostracism with gay sex being declared as an offence. Appearing before a bench of justices G S Singhvi and S J Mukhopadhaya, the...

-DNA Country’s first chief information commissioner (CIC), Wajahat Habibullah, told law and mass communication students about the true strength of the Right To Information (RTI) Act, 2005. He said RTI Act is not a weapon to be used against the government but to strengthen the system, exposing the weaknesses within its functioning. He was speaking at a daylong workshop on ‘RTI and media—Partners for priority’ organised by Symbiosis Institute of Media and...

-The Hindu As it stands on the threshold of the Twelfth Plan, India has a historic opportunity to elevate education and healthcare as the strongest pillars of its future development. Yearning for life-building education is unprecedented today. Yet, as Amartya Sen pointed out last year, the system remains deeply unjust. Access to excellence is open to those who can afford it, while the less-affluent majority has been left behind without even...

It is common for government agencies to come up with reasons for not supplying information sought under the Right to Information Act (RTI). Now, the state civil supplies department has come up with a googly. Responding to a RTI query, it told the applicant, "pay us money so that we can hire people to find out the information you seek."  The applicant, M Thirumani of Padikuppam Road in Anna Nagar, filed...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...